Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?

od Kohyama, Kuniko, Matsumoto, Yoh
Wydane w Immunotargets Ther (2015)

Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of Aβ Species and Amyloidogenic Peptides

od Matsumoto, Yoh, Niimi, Naoko, Kohyama, Kuniko
Wydane 2013

B-Cell Epitope Spreading Is a Critical Step for the Switch from C-Protein-Induced Myocarditis to Dilated Cardiomyopathy

od Matsumoto, Yoh, Park, Il-Kwon, Kohyama, Kuniko
Wydane 2007

Interleukin-1 Stimulates Glutamate Uptake in Glial Cells by Accelerating Membrane Trafficking of Na(+)/K(+)-ATPase via Actin Depolymerization

od Namekata, Kazuhiko, Harada, Chikako, Kohyama, Kuniko, Matsumoto, Yoh, Harada, Takayuki
Wydane 2008

Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats

od Matsumoto, Yoh, Park, Il-Kwon, Hiraki, Keiko, Ohtani, Shin, Kohyama, Kuniko
Wydane 2009

Nonviral Aβ DNA vaccine therapy against Alzheimer’s disease: Long-term effects and safety

od Okura, Yoshio, Miyakoshi, Akira, Kohyama, Kuniko, Park, Il-Kwon, Staufenbiel, Matthias, Matsumoto, Yoh
Wydane 2006

Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway

od Guo, Xiaoli, Harada, Chikako, Namekata, Kazuhiko, Matsuzawa, Atsushi, Camps, Monsterrat, Ji, Hong, Swinnen, Dominique, Jorand-Lebrun, Catherine, Muzerelle, Mathilde, Vitte, Pierre-Alain, Rückle, Thomas, Kimura, Atsuko, Kohyama, Kuniko, Matsumoto, Yoh, Ichijo, Hidenori, Harada, Takayuki
Wydane 2010